Repurposing glucocorticoids as adjuvant reagents for immune checkpoint inhibitors in solid cancers
Saved in:
Main Author: | Yingyan Yu |
---|---|
Format: | article |
Language: | EN |
Published: |
China Anti-Cancer Association
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/676103e2d9b549fea31e5a6893d8b918 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acute kidney injury in patients treated with immune checkpoint inhibitors
by: Enriqueta Felip, et al.
Published: (2021) -
Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy
by: Andrew Haydon, et al.
Published: (2021) -
Neoadjuvant immune checkpoint inhibitor plus chemotherapy in rare tracheal tumors
by: Ben‐Yuan Jiang, et al.
Published: (2021) -
Activated osteoarthritis following immune checkpoint inhibitor treatment: an observational study
by: Anne R Bass, et al.
Published: (2021) -
68Ga-DOTATOC PET/CT to detect immune checkpoint inhibitor-related myocarditis
by: Joe-Elie Salem, et al.
Published: (2021)